Simplex Trading, LLC Chemo Centryx, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

Shares

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 03, 2022	SELL	$15.36 - $27.51 $932,275 - $1.67 Million	-60,695 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$22.22 - $39.12 $1.42 Million - $2.49 Million	-63,712 Reduced 51.21%	60,695 $1.52 Million
Q3 2021 Oct 28, 2021	BUY	$13.18 - $19.83 $25,134 - $37,815	1,907 Added 1.56%	124,407 $1.64 Million
Q2 2021 Aug 12, 2021	BUY	$9.59 - $50.88 $1.17 Million - $6.23 Million	122,500 New	122,500 $1.64 Million
Q4 2020 Feb 02, 2021	SELL	$47.25 - $65.16 $1.11 Million - $1.53 Million	-23,556 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$46.35 - $61.69 $72,259 - $96,174	1,559 Added 7.09%	23,556 $1.29 Million
Q2 2020 Jul 13, 2020	BUY	$38.58 - $65.07 $519,904 - $876,883	13,476 Added 158.15%	21,997 $1.27 Million
Q1 2020 Apr 29, 2020	BUY	$32.73 - $50.78 $278,892 - $432,696	8,521 New	8,521 $342,000
Q4 2019 Feb 05, 2020	SELL	$6.81 - $39.55 $206,983 - $1.2 Million	-30,394 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$6.47 - $8.96 $116,563 - $161,423	-18,016 Reduced 37.22%	30,394 $206,000
Q2 2019 Jul 26, 2019	BUY	$8.31 - $14.85 $91,484 - $163,483	11,009 Added 29.44%	48,410 $450,000
Q1 2019 Apr 18, 2019	BUY	$10.01 - $13.89 $310,059 - $430,242	30,975 Added 482.03%	37,401 $0
Q4 2018 Jan 16, 2019	SELL	$9.15 - $12.26 $103,651 - $138,881	-11,328 Reduced 63.81%	6,426 $70,000
Q3 2018 Oct 23, 2018	BUY	$10.49 - $13.72 $94,724 - $123,891	9,030 Added 103.51%	17,754 $224,000
Q2 2018 Jul 30, 2018	BUY	$10.62 - $13.98 $81,158 - $106,835	7,642 Added 706.28%	8,724 $114,000
Q1 2018 Apr 26, 2018	BUY	$5.9 - $14.99 $6,342 - $16,114	1,075 Added 15357.14%	1,082 $14,000
Q4 2017 Jan 10, 2018	SELL	$5.53 - $8.42 $2,294 - $3,494	-415 Reduced 98.34%	7 $0
Q3 2017 Oct 25, 2017	BUY	$6.5 - $10.69 $2,743 - $4,511	422	422 $3,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.